UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Epilepsy, anti-seizure medication, intellectual disability and challenging behaviour - Everyone's business, no one's priority

Kinney, MO; Chester, V; Tromans, S; Alexander, RT; Angus-Leppan, H; Bagary, M; Cock, H; ... Shankar, R; + view all (2020) Epilepsy, anti-seizure medication, intellectual disability and challenging behaviour - Everyone's business, no one's priority. Seizure , 81 pp. 111-116. 10.1016/j.seizure.2020.07.018. Green open access

[thumbnail of Hassiotis_Epilepsy, anti-seizure medication, intellectual disability and challenging behaviour - Everyone's business, no one's priority_VoR.pdf]
Preview
Text
Hassiotis_Epilepsy, anti-seizure medication, intellectual disability and challenging behaviour - Everyone's business, no one's priority_VoR.pdf - Published Version

Download (438kB) | Preview

Abstract

PURPOSE: People with Intellectual Disability (ID) and epilepsy are more likely to experience psychiatric conditions, challenging behaviour (CB), treatment resistance and adverse effects of anti-seizure medications (ASM) than those without. This population receives care from various professionals, depending on local care pathways. This study evaluates the training status, confidence, reported assessment and management practices of different professional groups involved in caring for people with ID, epilepsy and CB. METHODS: A cross sectional survey using a questionnaire developed by expert consensus which measured self-reported training status, confidence, and approaches to assessment and management of CB in people with ID and epilepsy was distributed to practitioners involved in epilepsy and/or ID. RESULTS: Of the 83 respondents, the majority had either a psychiatry/ID (n = 39), or Neurology/epileptology background (n = 31). Psychiatry/ID and Neurology/epileptology had similar confidence in assessing CB in ID-epilepsy cases, but Psychiatry/ID exhibited higher self-rated confidence in the management of these cases. While assessing and managing CB, Psychiatry/ID appeared more likely to consider mental health aspects, while Neurology/epileptology typically focused on ASM. CONCLUSION: Psychiatry/ID and Neurology/epileptology professionals had varying training levels in epilepsy, ID and CB, had differing confidence levels in managing this patient population, and considered different factors when approaching assessment and management. As such, training opportunities in ID should be offered to neurology professionals, and vice versa. Based on the findings, a best practice checklist is presented, which aims to provide clinicians with a structured framework to consider causal explanations for CB in this population.

Type: Article
Title: Epilepsy, anti-seizure medication, intellectual disability and challenging behaviour - Everyone's business, no one's priority
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.seizure.2020.07.018
Publisher version: https://doi.org/10.1016/j.seizure.2020.07.018
Language: English
Additional information: © 2020 The Author(s). Published by Elsevier Ltd on behalf of British Epilepsy Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Anti-seizure medication, Learning disability, epilepsy
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Division of Psychiatry
URI: https://discovery.ucl.ac.uk/id/eprint/10107806
Downloads since deposit
42Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item